The woman shot and killed by an Immigration and Customs Enforcement agent in Minneapolis was a loving mother, a poet and a partner whose family – along with neighbors across her stunned city and ...
Parents these days always want to go above and beyond to give their children memorable learning experiences and a strong ...
With laundry detergent prices rising, I put the cheapest and most expensive non-bio capsules from my local Sainsbury's to the ...
The new year has ushered in a flow of biotech-specific funds, including $700 million from Andreessen Horowitz (A16z). | The ...
BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...
Analytical Biological Services, Inc. ("ABS Bio" or "the Company"), a 3 Boomerang Capital ("3 Boomerang" or "3BC") portfolio ...
12hon MSN
Commercially viable biomanufacturing: Designer yeast turns sugar into lucrative chemical 3-HP
Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...
Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized ...
The Atlanta Falcons are on the hunt for a new head coach. All the information for their search for a new leader of the ...
Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...
As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.
The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results